PALUMBO, CARLOTTA
 Distribuzione geografica
Continente #
AS - Asia 1.716
EU - Europa 1.684
NA - Nord America 1.019
SA - Sud America 149
AF - Africa 47
AN - Antartide 1
OC - Oceania 1
Totale 4.617
Nazione #
US - Stati Uniti d'America 956
SG - Singapore 932
IE - Irlanda 757
HK - Hong Kong 353
SE - Svezia 267
CN - Cina 218
RU - Federazione Russa 218
DE - Germania 180
BR - Brasile 117
VN - Vietnam 74
IT - Italia 64
GB - Regno Unito 50
CA - Canada 42
KR - Corea 40
FI - Finlandia 35
BJ - Benin 26
IN - India 25
PL - Polonia 21
FR - Francia 20
UA - Ucraina 18
MX - Messico 17
ID - Indonesia 16
BD - Bangladesh 15
JP - Giappone 13
NL - Olanda 13
PE - Perù 11
ZA - Sudafrica 11
TR - Turchia 10
ES - Italia 8
AR - Argentina 7
LT - Lituania 7
IQ - Iraq 6
AT - Austria 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CO - Colombia 3
IL - Israele 3
LV - Lettonia 3
MA - Marocco 3
PY - Paraguay 3
SA - Arabia Saudita 3
PK - Pakistan 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UZ - Uzbekistan 2
AQ - Antartide 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
HN - Honduras 1
KE - Kenya 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
SR - Suriname 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.617
Città #
Dublin 755
Hong Kong 353
Singapore 265
Beijing 141
Ashburn 110
Lawrence 107
Princeton 107
Bremen 78
Los Angeles 71
Seoul 40
Helsinki 33
Boardman 29
Buffalo 29
Ho Chi Minh City 29
Munich 29
Cotonou 26
New York 22
São Paulo 19
Warsaw 19
Hanoi 16
London 16
Santa Clara 16
Toronto 15
Chennai 14
Montreal 14
Atlanta 12
Brooklyn 12
Dallas 12
Mexico City 12
Tokyo 12
Boston 11
Chicago 11
Lima 11
Denver 10
Frankfurt am Main 10
Genoa 10
Novara 10
Amsterdam 8
Johannesburg 8
Poplar 8
Jacksonville 7
Moscow 7
Stockholm 7
Tianjin 7
Ankara 6
Assago 6
Houston 6
Milan 6
Orem 6
Phoenix 6
Dhaka 5
Falkenstein 5
Manchester 5
Nuremberg 5
Alessandria 4
Biên Hòa 4
Brno 4
Chandler 4
Des Moines 4
Guayaquil 4
Portland 4
Roubaix 4
San Francisco 4
Seattle 4
Austin 3
Baghdad 3
Bismarck 3
Brussels 3
Curitiba 3
Guangzhou 3
Istanbul 3
Mumbai 3
Ottawa 3
Paris 3
Pittsburgh 3
Raleigh 3
Riga 3
Rio de Janeiro 3
Thái Nguyên 3
Vienna 3
Wilmington 3
Angra dos Reis 2
Arezzo 2
Asunción 2
Belo Horizonte 2
Berlin 2
Charleston 2
Charlotte 2
Dakar 2
Elk Grove Village 2
Fortaleza 2
Galliate 2
Garden Grove 2
Goiânia 2
Guarulhos 2
Gunzenhausen 2
Hải Dương 2
Jeddah 2
Juiz de Fora 2
Lahore 2
Totale 2.723
Nome #
Assessment of predictors of renal cell carcinoma progression after nephrectomy at short and intermediate term follow-up and implication on surveillance protocols 90
Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature? 81
Is active surveillance a safe option for small RCCs as it is for small renal masses? 72
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 64
Bladder tumours in children: An interesting case report of TCC with a partial inverted growth pattern 60
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 60
Bladder cancer incidence rates and trends in young adults aged 20-39 years 56
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates 56
Bone mineral density and frax score may not predict fracture risk in patients with cancer undergoing hormone deprivation therapies 56
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 56
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 56
Risk of recurrence after nephrectomy: Comparison of predictive ability of validated risk models 55
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 54
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages 53
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 52
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 52
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes 52
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality 52
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 51
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: A systematic review 51
Primary large cell neuroendocrine carcinoma of the renal pelvis: a case report 50
Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group 50
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 49
Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma 49
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 48
Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) 47
Robotic prostatectomy: An update on functional and oncologic outcomes 47
Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis 46
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma 46
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 46
Adherence to guideline recommendations for multimodality treatment of patients with pT2–3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes 46
Analysis of circulating tumor cells in prostate cancer patients at psa recurrence and review of the literature 45
Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263 44
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 44
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 43
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study. 42
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 42
Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer 42
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample 42
Perineural invasion as a predictor of extraprostatic extension of prostate cancer: A systematic review and meta-analysis 42
Partial nephrectomy in frail patients: Benefits of robot-assisted surgery 42
Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration 41
Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy 41
Concordance between biopsy and radical prostatectomy specimen gleason score in internal and external pathology facilities 40
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 39
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 39
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 39
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 39
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 38
Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities 38
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 38
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy 38
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma 37
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 37
Massive recurring angiomyxoma of the scrotum in a obese man 36
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 36
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 36
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm 35
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 35
Partial nephrectomy for renal tumors: recommendations of the Italian Society of Urology RCC working group 34
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 34
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 34
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 34
Sex- and age-related differences in the distribution of bladder cancer metastases 34
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 34
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 34
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma 34
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 33
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 33
Prostate cancer grade and stage misclassification in active surveillance candidates: Black versus white patients 32
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma 32
Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality 32
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 32
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder 31
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer 31
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma 31
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 31
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 31
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study 31
Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay 30
Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis 30
Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma 30
Conditional survival of patients with nonmetastatic renal cell carcinoma: How cancer-specific mortality changes after nephrectomy 30
Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer 30
Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: The brescia experience 30
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 30
Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) 29
Racial differences in the distribution of bladder cancer metastases: A population-based analysis 29
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 29
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 29
Prostate cancer characteristics and cancer-specific mortality of Native American patients 29
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 29
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 28
Trends and social barriers for inpatient palliative care in patients with metastatic bladder cancer receiving critical care therapies 28
Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based study 28
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study 28
Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors 28
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients 28
Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies 28
Reply to Wei Qi’s letter to the editor about “Preoperative proteinuria correlates with renal function after partial nephrectomy for renal cell carcinoma” 27
Totale 4.072
Categoria #
all - tutte 36.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 1 0 1 0 1 0
2021/2022134 1 2 1 2 0 0 0 0 5 0 13 110
2022/20231.206 142 70 53 3 80 67 13 75 687 7 7 2
2023/2024458 17 34 40 15 100 0 145 2 3 6 8 88
2024/20251.454 42 3 67 9 26 43 163 88 445 303 21 244
2025/20261.393 206 236 191 357 355 48 0 0 0 0 0 0
Totale 4.661